Skip to main content
SpringerLink
Log in

IL-17, a potential therapeutic target for Sjögren’s syndrome?

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fei Y, Zhang W, Lin D et al (2014) Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren’s syndrome. Clin Rheumatol 33(4):523–529

    Article  PubMed  Google Scholar 

  2. Ciccia F, Guggino G, Rizzo A et al (2012) Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren’s syndrome. Ann Rheum Dis 71(2):295–301

    Article  CAS  PubMed  Google Scholar 

  3. Tan X, Sun S, Liu Y et al (2014) Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome. Eye (Lond). doi:10.1038/eye.2014.38

    Google Scholar 

  4. Lee SY, Han SJ, Nam SM et al (2013) Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients. Am J Ophthalmol 156(2):247–253

    Article  CAS  PubMed  Google Scholar 

  5. Miletic M, Stojanovic R, Pajic O et al (2012) Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren’s syndrome. Indian J Med Res 135(4):513–519

    PubMed Central  CAS  PubMed  Google Scholar 

  6. Lin X, Rui K, Deng J et al (2014) Th17 cells play a critical role in the development of experimental Sjogren’s syndrome. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-204584

    PubMed Central  Google Scholar 

  7. Nguyen CQ, Yin H, Lee BH et al (2010) Pathogenic effect of interleukin-17A in induction of Sjögren’s syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther 12(6):R220

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Alunno A, Bistoni O, Bartoloni E et al (2013) IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren’s syndrome. Ann Rheum Dis 72(2):286–292

    Article  CAS  PubMed  Google Scholar 

  9. Ciccia F, Guggino G, Rizzo A et al (2014) Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjogren's syndrome. Rheumatology (Oxford). doi:10.1093/rheumatology/keu004

    Google Scholar 

Download references

Conflict of interest

The authors have no potential conflicts of interest.

Author information

Authors and Affiliations

  1. Shanghai Pudong Institute for Health Development, 818 Laiyang Road, Pudong, Shanghai, People’s Republic of China

    Shan-Shan Liu, Ye Ding & Ji-Quan Lou

Authors
  1. Shan-Shan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ye Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ji-Quan Lou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ji-Quan Lou.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, SS., Ding, Y. & Lou, JQ. IL-17, a potential therapeutic target for Sjögren’s syndrome?. Clin Rheumatol 34, 1657–1658 (2015). https://doi.org/10.1007/s10067-014-2621-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-014-2621-3

Keywords

Search

Navigation